annual CFI:
-$106.10M-$18.92M(-21.70%)Summary
- As of today (June 26, 2025), SPRY annual cash flow from investing activities is -$106.10 million, with the most recent change of -$18.92 million (-21.70%) on December 31, 2024.
- During the last 3 years, SPRY annual CFI has fallen by -$106.05 million (-192810.91%).
Performance
SPRY Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$29.06M+$130.82M(+128.56%)Summary
- As of today (June 26, 2025), SPRY quarterly cash flow from investing activities is $29.06 million, with the most recent change of +$130.82 million (+128.56%) on March 31, 2025.
- Over the past year, SPRY quarterly CFI has increased by +$37.58 million (+441.41%).
- SPRY quarterly CFI is now -35.37% below its all-time high of $44.97 million, reached on June 30, 2023.
Performance
SPRY quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$68.52M+$37.58M(+35.42%)Summary
- As of today (June 26, 2025), SPRY TTM cash flow from investing activities is -$68.52 million, with the most recent change of +$37.58 million (+35.42%) on March 31, 2025.
- Over the past year, SPRY TTM CFI has dropped by -$84.38 million (-532.25%).
- SPRY TTM CFI is now -415.81% below its all-time high of $21.70 million, reached on September 30, 2024.
Performance
SPRY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SPRY Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.7% | +441.4% | -532.3% |
| 3 y3 years | -10000.0% | +10000.0% | -10000.0% |
| 5 y5 years | -100.0% | - | - |
SPRY Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -35.4% | +126.1% | -415.8% | +39.5% |
| 5 y | 5-year | <-9999.0% | at low | -35.4% | +126.1% | -415.8% | +39.5% |
| alltime | all time | <-9999.0% | at low | -35.4% | +126.1% | -415.8% | +39.5% |
SPRY Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $29.06M(-128.6%) | -$68.52M(-35.4%) |
| Dec 2024 | -$106.10M(+21.7%) | -$101.76M(-705.1%) | -$106.10M(-589.0%) |
| Sep 2024 | - | $16.82M(-233.0%) | $21.70M(-152.0%) |
| Jun 2024 | - | -$12.65M(+48.5%) | -$41.76M(-363.4%) |
| Mar 2024 | - | -$8.51M(-132.7%) | $15.85M(-118.2%) |
| Dec 2023 | -$87.18M | $26.04M(-155.8%) | -$87.18M(-23.1%) |
| Sep 2023 | - | -$46.64M(-203.7%) | -$113.34M(+69.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $44.97M(-140.3%) | -$66.73M(-40.3%) |
| Mar 2023 | - | -$111.55M(>+9900.0%) | -$111.72M(>+9900.0%) |
| Dec 2022 | -$199.00K(+261.8%) | -$126.00K(+320.0%) | -$199.00K(+172.6%) |
| Sep 2022 | - | -$30.00K(+36.4%) | -$73.00K(+69.8%) |
| Jun 2022 | - | -$22.00K(+4.8%) | -$43.00K(+104.8%) |
| Mar 2022 | - | -$21.00K | -$21.00K |
| Dec 2021 | -$55.00K(<-9900.0%) | - | - |
| Dec 2020 | $0.00 | - | - |
FAQ
- What is ARS Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual CFI year-on-year change?
- What is ARS Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly CFI year-on-year change?
- What is ARS Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM CFI year-on-year change?
What is ARS Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of SPRY is -$106.10M
What is the all time high annual CFI for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual cash flow from investing activities is $0.00
What is ARS Pharmaceuticals annual CFI year-on-year change?
Over the past year, SPRY annual cash flow from investing activities has changed by -$18.92M (-21.70%)
What is ARS Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of SPRY is $29.06M
What is the all time high quarterly CFI for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly cash flow from investing activities is $44.97M
What is ARS Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, SPRY quarterly cash flow from investing activities has changed by +$37.58M (+441.41%)
What is ARS Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of SPRY is -$68.52M
What is the all time high TTM CFI for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM cash flow from investing activities is $21.70M
What is ARS Pharmaceuticals TTM CFI year-on-year change?
Over the past year, SPRY TTM cash flow from investing activities has changed by -$84.38M (-532.25%)